AGP Picks
View all

Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

Press releases published on September 23, 2026

Censinet Earns 'Outstanding' Rating on TIME's World's Top HealthTech Companies of 2026
UltraSight Raises $24 Million to Scale Its AI-Guided Cardiac Workflow Platform Across U.S. Health Systems
LiveData Insights Adds Comprehensive Financial Analytics to Operating Room Reports
Petrolíferos Lobo and Oz Studio Expand TRACE From Petroleum Into Pharmaceutical and Supplement Traceability
NexLife Includes a Licensed Doctor, a Nutrition Plan and Health Check-Ins After Treatment Starts in Every Compounded GLP-1 Subscription
Avis aux médias : MADD Canada dévoilera un nouveau panneau commémoratif routier en hommage à Sophie Schnurr
Media Advisory: MADD Canada to Unveil New Roadside Memorial Sign Honouring Sophie Schnurr
Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets
Cheryl Polmatier Joins U.S. Oral Surgery Management as SVP of Payer Relations
NEXGEL Announces Dial-In Details for Investor Update Call
MAIA Biotechnology Expands Pivotal Phase 3 THIO-104 Non-Small Cell Lung Cancer Trial into Spain and Portugal
Virtuix Expands Autism Therapy Program with New Partner and Multi-Site Pilot Beginning January 2027
BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission
Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies
Pycnogenol® Offers Clinically Backed Cognitive Support Across Generations
IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference
Palisade Bio Expands Global Phase 2b ASCENTRA-UC Program with Health Canada CTA Clearance
SciSparc: Subsidiary NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with Clearmind Covering LSD, Ketamine and Ibogaine Combinations
Parexel Transforms Functional Service Provider (FSP) Model to Improve R&D Productivity and Enhance Post-Approval Product Lifecycle Services for Biopharmaceutical Companies
Actinogen XanaMIA pivotal Alzheimer’s disease trial completes final patient visit, with topline results on track for November

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Massachusetts Healthcare Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.